First Time Loading...
H

Hillevax Inc
NASDAQ:HLVX

Watchlist Manager
Hillevax Inc
NASDAQ:HLVX
Watchlist
Price: 12.67 USD -1.71% Market Closed
Updated: May 29, 2024

Hillevax Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hillevax Inc
Total Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
Hillevax Inc
NASDAQ:HLVX
Total Current Liabilities
$29.3m
CAGR 3-Years
107%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$41.5B
CAGR 3-Years
9%
CAGR 5-Years
24%
CAGR 10-Years
21%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$13B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$19.7B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$3.8B
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.6B
CAGR 3-Years
4%
CAGR 5-Years
19%
CAGR 10-Years
28%

See Also

What is Hillevax Inc's Total Current Liabilities?
Total Current Liabilities
29.3m USD

Based on the financial report for Dec 31, 2023, Hillevax Inc's Total Current Liabilities amounts to 29.3m USD.

What is Hillevax Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
107%

Over the last year, the Total Current Liabilities growth was 125%. The average annual Total Current Liabilities growth rates for Hillevax Inc have been 107% over the past three years .